All In Biotech

Drug Trial Radar · NCT01071876

BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS

BF2.649 in Patients With Obstructive Sleep Apnea Syndrome (OSA) and Treated by Nasal Continuous Positive Airway Pressure (nCPAP), But Still Complaining of Excessive Daytime Sleepiness (EDS)

Last checked: Nov 19, 2026Latest source record: Jan 21, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 244 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

244

Actual

Start

Aug 2011

Primary completion

Mar 2014

Study completion Mar 2014

Sponsor

Lead sponsor
BioprojetAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 19, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Multicenter randomized double blind study versus placebo during 12 weeks with at first, an escalating dose period followed by stable dose period at the selected dose. This double-blind period can be followed by a 9 months open-label period if the patient wishes to continue with the study product.

Conditions

  • Obstructive Sleep Apnea
  • Excessive Daytime Sleepiness

Interventions

  • BF2.649Drug

    1 capsule in the morning before breakfast

  • PlaceboDrug

    1 capsule in the morning before breakfast

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. ESS change (Epworth Sleepiness Scale)Time frame: at week 12 /52 versus baseline

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • CHU Grenoble

    Grenoble, France

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.